A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Pfizer
Shanghai Zhongshan Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Centre hospitalier de l'Université de Montréal (CHUM)
University Hospital, Lille
Fujian Medical University Union Hospital
Northwestern University
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Second Life Therapeutics
Henan Cancer Hospital
AHS Cancer Control Alberta
West China Hospital
Fujian Medical University Union Hospital
Ruijin Hospital
Asan Medical Center
University Medical Center Groningen
Shenyang Sunshine Pharmaceutical Co., LTD.
Case Comprehensive Cancer Center
Sichuan University
The First Affiliated Hospital of Guangzhou Medical University
Chang Gung Memorial Hospital
Sun Yat-sen University
Sichuan University
Fujian Cancer Hospital
Sichuan University
Anhui Provincial Hospital
The First Affiliated Hospital of Xiamen University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Technische Universität Dresden
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Fujian Cancer Hospital
Sunshine Lake Pharma Co., Ltd.
Royal College of Surgeons, Ireland
Shanghai Chest Hospital
H. Lee Moffitt Cancer Center and Research Institute
Centre Leon Berard
Fudan University
University of Cologne
Sohag University
Fujian Cancer Hospital
Tianjin Medical University Cancer Institute and Hospital
Shanghai Weihe Medical Laboratory Co., Ltd.
Universidade Federal de Pernambuco
Anhui Provincial Hospital
Energenx Medical LTD.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hebei Medical University Fourth Hospital
Sun Yat-sen University
Erasmus Medical Center